Transmembrane ionic currents in atrial myocytes in sinus rhythm and chronic atrial fibrillation in human and animal models View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2010-2014

FUNDING AMOUNT

13994000.0 HUF

ABSTRACT

We have developed a new tachypaced chronic atrial fibrillation dog model (ATR). In dog ATR atrial myocytes Ito slightly downregulated, while IK1 upregulated. We have reported the clear presence of a ligand independent constitutively activated IKACh current in the dog ATR cells, which plays an important role in the atrial remodelling. We have investigated the effects of a novel IKur blocker substance XEND010, and we have concluded that due to its selectively IKur blocking effects, possess a strong Class III atrial selective antiarrhythmic potency. We have reported that administration of extremely high concentration of diclofenac (as for top athletes) attenuated RR, which may increase proarrhythmic tendency. We have showed that the racemic R-L3 compound, ZS 1271B is a potent IKs activator, which make it suitable for testing the antiarrhythmic property of the IKs activator drugs. We have observed that the antianginal drugs ivabradine and ranolazine possess also strong use dependent Na-channel blocking properties. We have reported that the Ca activated K+ channels contributed importantly to cardiac repolarization remodelling. By testing the novel NCX blocker drug ORM-10103, we clearly demonstrated that NCX blockade indeed have strong antiarrhythmic effect. We have reported that repolarization reserve in human myocardium is less than that observed in the dog, ie., the proarrhythmic effect several cardiac drugs can be underestimated in human based on experiments performed in dog. More... »

URL

http://nyilvanos.otka-palyazat.hu/index.php?menuid=930&num=82079&lang=EN

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "HUF", 
      "type": "MonetaryAmount", 
      "value": 13994000.0
    }, 
    "description": "We have developed a new tachypaced chronic atrial fibrillation dog model (ATR). In dog ATR atrial myocytes Ito slightly downregulated, while IK1 upregulated. We have reported the clear presence of a ligand independent constitutively activated IKACh current in the dog ATR cells, which plays an important role in the atrial remodelling. We have investigated the effects of a novel IKur blocker substance XEND010, and we have concluded that due to its selectively IKur blocking effects, possess a strong Class III atrial selective antiarrhythmic potency. We have reported that administration of extremely high concentration of diclofenac (as for top athletes) attenuated RR, which may increase proarrhythmic tendency. We have showed that the racemic R-L3 compound, ZS 1271B is a potent IKs activator, which make it suitable for testing the antiarrhythmic property of the IKs activator drugs. We have observed that the antianginal drugs ivabradine and ranolazine possess also strong use dependent Na-channel blocking properties. We have reported that the Ca activated K+ channels contributed importantly to cardiac repolarization remodelling. By testing the novel NCX blocker drug ORM-10103, we clearly demonstrated that NCX blockade indeed have strong antiarrhythmic effect. We have reported that repolarization reserve in human myocardium is less than that observed in the dog, ie., the proarrhythmic effect several cardiac drugs can be underestimated in human based on experiments performed in dog.", 
    "endDate": "2014-01-31", 
    "funder": {
      "id": "http://www.grid.ac/institutes/grid.452143.5", 
      "type": "Organization"
    }, 
    "id": "sg:grant.4193291", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "grant.4193291"
        ]
      }, 
      {
        "name": "otka_id", 
        "type": "PropertyValue", 
        "value": [
          "82079"
        ]
      }
    ], 
    "keywords": [
      "chronic atrial fibrillation", 
      "strong antiarrhythmic effect", 
      "proarrhythmic tendency", 
      "antiarrhythmic effects", 
      "atrial remodelling", 
      "proarrhythmic effects", 
      "atrial fibrillation", 
      "sinus rhythm", 
      "antiarrhythmic properties", 
      "antiarrhythmic potency", 
      "ORM-10103", 
      "cardiac drugs", 
      "animal models", 
      "human myocardium", 
      "dog model", 
      "atrial myocytes", 
      "repolarization reserve", 
      "NCX blockade", 
      "blocking properties", 
      "drug ivabradine", 
      "transmembrane ionic currents", 
      "activator drugs", 
      "dogs", 
      "drugs", 
      "remodelling", 
      "ionic currents", 
      "ivabradine", 
      "humans", 
      "fibrillation", 
      "blockade", 
      "IKACh", 
      "myocardium", 
      "administration", 
      "myocytes", 
      "important role", 
      "IK1", 
      "high concentrations", 
      "effect", 
      "potency", 
      "diclofenac", 
      "rhythm", 
      "RR", 
      "cells", 
      "activator", 
      "role", 
      "clear presence", 
      "presence", 
      "concentration", 
      "tendency", 
      "reserves", 
      "ligands", 
      "model", 
      "compounds", 
      "possess", 
      "Ca", 
      "channels", 
      "experiments", 
      "properties", 
      "current", 
      "ATR cell", 
      "ITO"
    ], 
    "name": "Transmembrane ionic currents in atrial myocytes in sinus rhythm and chronic atrial fibrillation in human and animal models", 
    "recipient": [
      {
        "id": "http://www.grid.ac/institutes/grid.9008.1", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Szeged", 
          "type": "Organization"
        }, 
        "familyName": "Jost", 
        "givenName": "Norbert", 
        "id": "sg:person.0640661174.40", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0640661174.40", 
        "roleName": "PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Szeged", 
          "type": "Organization"
        }, 
        "familyName": "Bitay", 
        "givenName": "Mikl\u00f3s", 
        "id": "sg:person.0623234751.01", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0623234751.01", 
        "roleName": "Co-PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Szeged", 
          "type": "Organization"
        }, 
        "familyName": "Mozos", 
        "givenName": "Ioana", 
        "id": "sg:person.0627307751.84", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0627307751.84", 
        "roleName": "Co-PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Szeged", 
          "type": "Organization"
        }, 
        "familyName": "Nagy", 
        "givenName": "Zs\u00f3fia", 
        "id": "sg:person.015374531740.31", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.015374531740.31", 
        "roleName": "Co-PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.4193291"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2022-09-02T16:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/grant/grant_67.jsonl", 
    "startDate": "2010-07-01", 
    "type": "MonetaryGrant", 
    "url": "http://nyilvanos.otka-palyazat.hu/index.php?menuid=930&num=82079&lang=EN"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.4193291'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.4193291'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.4193291'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.4193291'


 

This table displays all metadata directly associated to this object as RDF triples.

132 TRIPLES      18 PREDICATES      88 URIs      77 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:grant.4193291 schema:about anzsrc-for:11
2 schema:amount N74d37f7444694dabaa7c652f3be7ff69
3 schema:description We have developed a new tachypaced chronic atrial fibrillation dog model (ATR). In dog ATR atrial myocytes Ito slightly downregulated, while IK1 upregulated. We have reported the clear presence of a ligand independent constitutively activated IKACh current in the dog ATR cells, which plays an important role in the atrial remodelling. We have investigated the effects of a novel IKur blocker substance XEND010, and we have concluded that due to its selectively IKur blocking effects, possess a strong Class III atrial selective antiarrhythmic potency. We have reported that administration of extremely high concentration of diclofenac (as for top athletes) attenuated RR, which may increase proarrhythmic tendency. We have showed that the racemic R-L3 compound, ZS 1271B is a potent IKs activator, which make it suitable for testing the antiarrhythmic property of the IKs activator drugs. We have observed that the antianginal drugs ivabradine and ranolazine possess also strong use dependent Na-channel blocking properties. We have reported that the Ca activated K+ channels contributed importantly to cardiac repolarization remodelling. By testing the novel NCX blocker drug ORM-10103, we clearly demonstrated that NCX blockade indeed have strong antiarrhythmic effect. We have reported that repolarization reserve in human myocardium is less than that observed in the dog, ie., the proarrhythmic effect several cardiac drugs can be underestimated in human based on experiments performed in dog.
4 schema:endDate 2014-01-31
5 schema:funder grid-institutes:grid.452143.5
6 schema:identifier N2e334f27f8ee4c41a6caba3972e70660
7 Nbbe0b0f01865492387b3409ca43cd5af
8 schema:keywords ATR cell
9 Ca
10 IK1
11 IKACh
12 ITO
13 NCX blockade
14 ORM-10103
15 RR
16 activator
17 activator drugs
18 administration
19 animal models
20 antiarrhythmic effects
21 antiarrhythmic potency
22 antiarrhythmic properties
23 atrial fibrillation
24 atrial myocytes
25 atrial remodelling
26 blockade
27 blocking properties
28 cardiac drugs
29 cells
30 channels
31 chronic atrial fibrillation
32 clear presence
33 compounds
34 concentration
35 current
36 diclofenac
37 dog model
38 dogs
39 drug ivabradine
40 drugs
41 effect
42 experiments
43 fibrillation
44 high concentrations
45 human myocardium
46 humans
47 important role
48 ionic currents
49 ivabradine
50 ligands
51 model
52 myocardium
53 myocytes
54 possess
55 potency
56 presence
57 proarrhythmic effects
58 proarrhythmic tendency
59 properties
60 remodelling
61 repolarization reserve
62 reserves
63 rhythm
64 role
65 sinus rhythm
66 strong antiarrhythmic effect
67 tendency
68 transmembrane ionic currents
69 schema:name Transmembrane ionic currents in atrial myocytes in sinus rhythm and chronic atrial fibrillation in human and animal models
70 schema:recipient N26c3cfbc54b24df6a0e963995e4c8b57
71 Nc9038d2e3f7f48cfa643703d53842da5
72 Ncb360fce3b5b42b69abf71ce2719a4fc
73 Nefe56f37d51c44d0848206bdb4ba5f76
74 sg:person.015374531740.31
75 sg:person.0623234751.01
76 sg:person.0627307751.84
77 sg:person.0640661174.40
78 grid-institutes:grid.9008.1
79 schema:sameAs https://app.dimensions.ai/details/grant/grant.4193291
80 schema:sdDatePublished 2022-09-02T16:20
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher N32725d05b8c4407a85bfdcaa06fcbaa5
83 schema:startDate 2010-07-01
84 schema:url http://nyilvanos.otka-palyazat.hu/index.php?menuid=930&num=82079&lang=EN
85 sgo:license sg:explorer/license/
86 sgo:sdDataset grants
87 rdf:type schema:MonetaryGrant
88 N26c3cfbc54b24df6a0e963995e4c8b57 schema:member sg:person.015374531740.31
89 schema:roleName Co-PI
90 rdf:type schema:Role
91 N2e334f27f8ee4c41a6caba3972e70660 schema:name dimensions_id
92 schema:value grant.4193291
93 rdf:type schema:PropertyValue
94 N32725d05b8c4407a85bfdcaa06fcbaa5 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N74d37f7444694dabaa7c652f3be7ff69 schema:currency HUF
97 schema:value 13994000.0
98 rdf:type schema:MonetaryAmount
99 Nbbe0b0f01865492387b3409ca43cd5af schema:name otka_id
100 schema:value 82079
101 rdf:type schema:PropertyValue
102 Nc9038d2e3f7f48cfa643703d53842da5 schema:member sg:person.0623234751.01
103 schema:roleName Co-PI
104 rdf:type schema:Role
105 Ncb360fce3b5b42b69abf71ce2719a4fc schema:member sg:person.0627307751.84
106 schema:roleName Co-PI
107 rdf:type schema:Role
108 Nefe56f37d51c44d0848206bdb4ba5f76 schema:member sg:person.0640661174.40
109 schema:roleName PI
110 rdf:type schema:Role
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 rdf:type schema:DefinedTerm
113 sg:person.015374531740.31 schema:affiliation grid-institutes:None
114 schema:familyName Nagy
115 schema:givenName Zsófia
116 rdf:type schema:Person
117 sg:person.0623234751.01 schema:affiliation grid-institutes:None
118 schema:familyName Bitay
119 schema:givenName Miklós
120 rdf:type schema:Person
121 sg:person.0627307751.84 schema:affiliation grid-institutes:None
122 schema:familyName Mozos
123 schema:givenName Ioana
124 rdf:type schema:Person
125 sg:person.0640661174.40 schema:affiliation grid-institutes:None
126 schema:familyName Jost
127 schema:givenName Norbert
128 rdf:type schema:Person
129 grid-institutes:None schema:name University of Szeged
130 rdf:type schema:Organization
131 grid-institutes:grid.452143.5 schema:Organization
132 grid-institutes:grid.9008.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...